Further, we demonstrated that the GASC1 positivity was statistically significantly associated with improved relapse-free and breast cancer specific survival in patients who were treated with adjuvant radiotherapy or with adjuvant tamoxifen which supported the above results. The gene discussed is KDM4C; the disease is breast carcinoma.